David Fuller

Dr Fuller is an experienced pharmaceutical physician and pharmacist with more than 30 years of international experience across drug development, clinical research, regulatory strategy and commercialisation. He is currently Chief Medical Officer of Dimerix Limited (ASX: DXB), where he leads clinical development, regulatory engagement and medical strategy for the Companys renal focused therapeutic programs. He has extensive experience across the full drug development lifecycle, including pre clinical development, Phase I III clinical trials, regulatory approvals, product launches and post-marketing activities. He has successfully contributed to multiple regulatory submissions and approvals with major global agencies, including the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), and has led programs resulting in commercialised products across oncology, renal medicine, neurology and anti-infectives.